Aristotle Atlantic Partners’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $48.7M | Buy |
62,490
+19,294
| +45% | +$15M | 1.48% | 17 |
|
|
2025
Q1 | $35.7M | Buy |
43,196
+2,019
| +5% | +$1.67M | 1.2% | 25 |
|
|
2024
Q4 | $31.8M | Buy |
41,177
+15,608
| +61% | +$12M | 1% | 24 |
|
|
2024
Q3 | $22.7M | Buy |
25,569
+2,792
| +12% | +$2.47M | 0.7% | 38 |
|
|
2024
Q2 | $20.6M | Buy |
22,777
+14,503
| +175% | +$13.1M | 0.67% | 43 |
|
|
2024
Q1 | $6.44M | Buy |
8,274
+2,165
| +35% | +$1.68M | 0.21% | 69 |
|
|
2023
Q4 | $3.56M | Buy |
6,109
+5,609
| +1,122% | +$3.27M | 0.13% | 72 |
|
|
2023
Q3 | $269K | Hold |
500
| – | – | 0.01% | 94 |
|
|
2023
Q2 | $234K | Buy |
+500
| New | +$234K | 0.01% | 99 |
|